Viet Nam

Located in the Greater Mekong Subregion (GMS), Viet Nam became a signatory of the APLMA roadmap in 2015. The country hosted the 5th APLMA Senior Officials’ Meeting in 2020.

Having completed a Sustainability & Transition Assessment in 2021 ahead of anticipated donor reductions, sustainability planning is also an important focus area that Viet Nam is increasing its efforts towards malaria elimination. Initiated in 2023, their current priorities involve POR planning at both the national and subnational levels, as well as subnational verification and the certification of subnational elimination. By the end of 2023, 46 out of Viet Nam’s 63 provinces have been certified malaria-free.  

Viet Nam is part of the Regional Artemisinin-resistance Initiative (RAI), a special multi-country award from the Global Fund which aims to accelerate malaria elimination in the GMS, including drug-resistant P. falciparum malaria. Like other countries in the GMS, Viet Nam also faces the challenges of an increasing proportion of P. vivax malaria.

Currently among the countries making up 1% of the Asia Pacific’s malaria burden, Viet Nam aims to eliminate malaria by 2030.

2022
Indigenous cases
412
​Deaths​
0
Funding Gap % (Global Fund Cycle '23-'25)
8
Elimination target:
2027